Skip to content

Molecule to Commercialization Solutions

Dedicated Expertise Guides Your Product from Idea to Market

Bringing a topical or non-sterile liquid product to market requires navigating evolving regulatory expectations, supply-chain pressures, and the realities of commercial manufacturing. Many CDMOs claim end-to-end capability, yet few deliver a true continuum where development, testing, tech transfer, and commercial supply operate as a single, integrated system. At CPL, this integration forms the foundation of our work.

For more than 35 years, we have remained focused on semi-solids and non-sterile liquid drug products, not as one of many dosage forms, but as our entire business. That focus enables us to guide customers from the earliest stages of molecule assessment through full-scale, compliant commercial production with confidence, precision, and continuity.

CPL's Solution

A Fully Integrated Pathway from Molecule to Market

Industry Challenge

Fragmented vendors slow progress and increase risk.

A fully integrated, single-source pathway from molecule to market.

CPL consolidates formulation and analytical development, testing, manufacturing, packaging, and supply-chain support under one roof, eliminating handoffs and ensuring accountability.

Industry Challenge

Inconsistent communication derails timelines.

Cross-functional teams aligned from day one.

Pharmaceutical development, analytical, manufacturing, quality control, and supply chain operate as a unified ecosystem, reducing delays, increasing visibility, and keeping programs on schedule.

Industry Challenge

Tech transfers reset the learning curve.

Seamless tech transfer and phase-appropriate scaling.

CPL’s proven transfer framework ensures smooth progression from development to clinical to commercial manufacturing.

Industry Challenge

Pressure to accelerate timelines and reduce COGS while maintaining compliance.

Commercial-minded development and scalable processes.

CPL designs robust formulations and processes that are scalable, repeatable, and efficient, with long-term supply continuity in mind.

Everything Moves Forward, Under One Roof

  • Formulation development, analytical development, method validation, IVRT, and IVPT through our skin lab, and project management.

    Learn More

  • Comprehensive in-house capabilities that accelerate development, de-risk scale-up, and support lifecycle management.

    Learn More

  • Seamless movement from development to GMP manufacturing through proven, phase-appropriate pathways.

    Learn More

  • Robust, high-capacity production of semi-solids and non-sterile liquids, supported by deep process knowledge and decades of commercial experience.

    Learn More

  • Integrated final-dose packaging, including tubes, bottles, and nasal sprays, designed to meet regulatory and patient-use requirements.

    Learn More

  • A dedicated, transparent order-to-cash operation keeps programs on track and ensures reliable supply.

    Learn More

Why It Matters: Continuity Creates Certainty

Reduced Risk

Knowledge stays with the team that built it. No gaps, no re-learning, no misaligned vendors

Accelerated Timelines

Integrated development and manufacturing remove friction across stages

Greater Visibility & Control

Single governance, single project team, single communication pathway

Higher Quality, Better Compliance

One system, one culture, one quality framework aligned from R&D through commercial

Commitment.
Partnership. Legacy.

Leverage CPL’s 35 years of expertise in non-sterile liquids and semi-solids to ensure your program's success. We’ll support your product from molecule to market, or step in at any stage of its product lifecycle.

Partner with Us
man